NCT02582424View on ClinicalTrials.gov

Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study.

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

September 30, 2013

Conditions
Hyperlipidemia
Interventions
OTHER

PD-L0101

92% EPA+6 mg ATX+50 mg TCT GG BID

OTHER

placebo

placebo

Sponsors
All Listed Sponsors
lead

Primus Pharmaceuticals

INDUSTRY